ES2118794T3 - Nueva sintesis de compuestos de 19-nor-vitamina d. - Google Patents

Nueva sintesis de compuestos de 19-nor-vitamina d.

Info

Publication number
ES2118794T3
ES2118794T3 ES92304837T ES92304837T ES2118794T3 ES 2118794 T3 ES2118794 T3 ES 2118794T3 ES 92304837 T ES92304837 T ES 92304837T ES 92304837 T ES92304837 T ES 92304837T ES 2118794 T3 ES2118794 T3 ES 2118794T3
Authority
ES
Spain
Prior art keywords
vitamin
compounds
synthesis
new synthesis
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92304837T
Other languages
English (en)
Inventor
Hector Floyd Deluca
Heinrich Konstantine Schnoes
Kato Leonard Perlman
Rolf E Swenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2118794T3 publication Critical patent/ES2118794T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/53Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/532Cycloaliphatic phosphine oxides or thioxides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

SE DESCRIBE UNA SINTESIS CONVERGENTE DE COMPUESTOS DE 19-NOR VITAMINA D, ESPECIFICAMENTE 19-NOR-1O,25-DIHIDROXIVITAMINA D3. TAMBIEN SE PUEDE UTILIZAR LA SINTESIS FACILMENTE PARA PREPARAR OTROS COMPUESTOS DE 19-NOR EL PASO CLAVE EN LA SINTESIS ES UNA APLICACION ADECUADA DEL PROCEDIMIENTO DE LYTHGOE, ES DECIR UNA REACCION HORNER-WITTIG DEL ANION DE LITIO DE UN OXIDO DE FOSFINA CON UNA CETONA WINDAUS GRUNDMANN PARA FACILITAR, TRAS CUALQUIER DESPROTECCION NECESARIA, EL COMPUESTO DESEADO DE 19-NOR
ES92304837T 1991-05-28 1992-05-28 Nueva sintesis de compuestos de 19-nor-vitamina d. Expired - Lifetime ES2118794T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70591791A 1991-05-28 1991-05-28

Publications (1)

Publication Number Publication Date
ES2118794T3 true ES2118794T3 (es) 1998-10-01

Family

ID=24835479

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92304837T Expired - Lifetime ES2118794T3 (es) 1991-05-28 1992-05-28 Nueva sintesis de compuestos de 19-nor-vitamina d.

Country Status (11)

Country Link
US (7) US5281731A (es)
EP (1) EP0516410B1 (es)
JP (4) JP2648845B2 (es)
KR (3) KR0160784B1 (es)
AT (1) ATE168996T1 (es)
AU (2) AU650751B2 (es)
CA (2) CA2069374C (es)
DE (1) DE69226402T2 (es)
DK (1) DK0516410T3 (es)
ES (1) ES2118794T3 (es)
IE (1) IE921700A1 (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
US5464866A (en) * 1992-08-17 1995-11-07 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
DE69400495T2 (de) * 1993-04-05 1997-04-30 Wisconsin Alumni Res Found 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle
CA2166898C (en) * 1993-07-09 2004-09-07 Roger Bouillon Novel structural analogues of vitamin d
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
ATE176462T1 (de) * 1994-11-21 1999-02-15 Wisconsin Alumni Res Found 18,19-dinor-vitamin-d-derivate
US5597815A (en) * 1995-07-13 1997-01-28 Wisconsin Alumni Research Foundation Prevention of hyperphosphatemia in kidney disorder patients
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6306844B1 (en) 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US6392071B1 (en) 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6316642B1 (en) 1997-03-17 2001-11-13 Wisconsin Alumni Research Foundation 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
EP0983221B1 (en) * 1997-05-23 2002-04-03 Basilea Pharmaceutica AG Cyclohexanediol derivatives
US5936105A (en) * 1997-06-13 1999-08-10 Tetrionics, Inc. 14-EPI-19-nor-vitamin D compounds and methods
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
AU762481C (en) * 1998-03-27 2004-08-19 Oregon Health Sciences University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
US6080879A (en) * 1998-05-19 2000-06-27 Tetrionics, Inc. Hexafluoro-vitamin synthesis and crystallization method, solvent and product
US6114317A (en) 1998-05-21 2000-09-05 Wisconsin Alumni Research Foundation Method of locking 1α-OH of vitamin D compounds in axial orientation
US5962707A (en) * 1998-08-18 1999-10-05 Wisconsin Alumni Research Foundation 19-nor-vitamin D3 compounds with calcemic activity
US6603030B1 (en) 1999-04-22 2003-08-05 Hoffman-La Roche Inc. Process for producing phosphineoxide vitamin D precursors
US6310262B1 (en) 1999-10-18 2001-10-30 Basilea Pharmaceutica Ag Process for preparing retiferol derivatives
DE10019861A1 (de) * 2000-04-18 2001-10-31 Schering Ag Neues Synthesezwischenprodukt, seine mikrobiologische Herstellung und Verwendung zur Synthese von Vitamin D-Derivaten
JP4022141B2 (ja) 2000-05-31 2007-12-12 ウィスコンシン・アルムニ・リサーチ・ファウンデーション 2−エチル及び2−エチリデン−19−ノル−ビタミンd化合物
JP4811547B2 (ja) * 2000-10-24 2011-11-09 史衛 佐藤 光学活性シクロヘキセン化合物の製造法及びこの製造に用いる光学活性シクロヘキセン誘導体
US6683219B2 (en) * 2001-07-30 2004-01-27 Wisconsin Alumni Research Foundation Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
WO2003026445A1 (en) * 2001-09-27 2003-04-03 The Coca-Cola Company Vitamin fortification of foodstuffs
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
US7023347B2 (en) * 2002-08-02 2006-04-04 Symbol Technologies, Inc. Method and system for forming a die frame and for transferring dies therewith
ATE556999T1 (de) 2003-04-10 2012-05-15 Wisconsin Alumni Res Found 2-propyliden-19-nor-vitamin d verbindungen
US20040250417A1 (en) * 2003-06-12 2004-12-16 Arneson Michael R. Method, system, and apparatus for transfer of dies using a die plate
US6894037B2 (en) 2003-07-03 2005-05-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
US7713951B2 (en) 2004-04-09 2010-05-11 Wisconsin Alumni Research Foundation 2-alkylidene-18,19-dinor-vitamin D compounds
US20060012387A1 (en) * 2004-06-29 2006-01-19 Symbol Technologies, Inc. Systems and methods for testing radio frequency identification tags
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060225273A1 (en) * 2005-03-29 2006-10-12 Symbol Technologies, Inc. Transferring die(s) from an intermediate surface to a substrate
EP1922303A2 (en) * 2005-07-18 2008-05-21 Teva Pharmaceutical Industries Ltd Purification of paricalcitol
US20070107186A1 (en) * 2005-11-04 2007-05-17 Symbol Technologies, Inc. Method and system for high volume transfer of dies to substrates
US20070131016A1 (en) * 2005-12-13 2007-06-14 Symbol Technologies, Inc. Transferring die(s) from an intermediate surface to a substrate
US20070139057A1 (en) * 2005-12-15 2007-06-21 Symbol Technologies, Inc. System and method for radio frequency identification tag direct connection test
WO2007105773A1 (ja) 2006-03-15 2007-09-20 Mercian Corporation インデン誘導体の製造方法およびその製造中間体
JP2009532482A (ja) 2006-04-05 2009-09-10 ウイスコンシン アラムニ リサーチ ファンデーション 1α−ヒドロキシ−2−(3’−ヒドロキシプロピリデン)−19−ノル−ビタミンD化合物類及びそれらの製造及び使用方法
US20070244657A1 (en) * 2006-04-11 2007-10-18 Drago Randall A Methods and systems for testing radio frequency identification (RFID) tags having multiple antennas
CA2668544A1 (en) 2006-11-02 2008-05-08 Mercian Corporation Process for production of 1-hydroxy-19-norcyclovitamin d derivative and intermediate for the production
CA2688083C (en) * 2007-05-30 2015-07-07 Cytochroma Inc. Process for producing phosphine oxide vitamin d precursors
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
US20090275768A1 (en) 2008-04-30 2009-11-05 Formosa Laboratories, Inc. Preparation of Paricalcitol
CA2639477C (en) * 2008-09-11 2016-03-22 Alphora Research Inc. Paricalcitol purification
US8013176B2 (en) * 2008-09-11 2011-09-06 Alphora Research Inc. Paricalcitol purification
KR20170096238A (ko) * 2009-01-27 2017-08-23 베르그 엘엘씨 화학요법과 연관된 부작용을 경감시키기 위한 비타민 d3 및 이의 유사물
JP5978130B2 (ja) 2009-08-14 2016-08-24 バーグ エルエルシー 脱毛症を治療するためのビタミンd3およびその類似体
CN101671288B (zh) * 2009-10-14 2013-10-30 兰州大学 帕立骨化醇的中间体的制备方法
EP3003497B1 (en) 2013-05-29 2024-02-14 BPGbio, Inc. Preventing or mitigating chemotherapy induced alopecia using vitamin d
CN107501317B (zh) * 2017-09-13 2019-08-16 上海皓元医药股份有限公司 一种帕立骨化醇中间体的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607118A (en) * 1981-04-30 1986-08-19 Philip Morris Incorporated Flavor-release β-hydroxy-ester compositions
ATE34977T1 (de) * 1983-01-28 1988-06-15 Hoffmann La Roche Verfahren zur herstellung von cholecalciferolderivaten.
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
EP0126713B1 (de) * 1983-05-18 1989-01-18 Ciba-Geigy Ag Cyclohexandion-carbonsäurederivate mit herbizider und das Pflanzenwachstum regulierender Wirkung
US4668817A (en) * 1983-12-21 1987-05-26 International Flavors & Fragrances Inc. Alkyl substituted para-carboalkoxy cyclohexanones
US4681976A (en) * 1983-12-21 1987-07-21 International Flavors & Fragrances Inc. Process for preparing alkyl substituted and unsubstituted para-carboalkoxy cyclohexanones
DE3565401D1 (de) * 1984-02-08 1988-11-10 Hoffmann La Roche Calciferol derivatives
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
ZA859138B (en) * 1984-12-19 1986-08-27 Hoffmann La Roche Cholecalciferol derivatives
US4755329A (en) * 1985-06-10 1988-07-05 Wisconsin Alumni Research Foundation Process and intermediates for preparing 1α-hydroxyvitamin D compounds
AU603340B2 (en) * 1985-08-02 1990-11-15 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US4847012A (en) * 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
FR2631025B1 (fr) * 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
US5232836A (en) * 1988-05-04 1993-08-03 Ire-Medgenix S.A. Vitamin D derivatives: therapeutic applications and applications to assays of metabolites of vitamin D
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds

Also Published As

Publication number Publication date
JPH05221960A (ja) 1993-08-31
KR0160784B1 (ko) 1999-01-15
EP0516410B1 (en) 1998-07-29
AU659774B2 (en) 1995-05-25
CA2191993C (en) 2002-07-09
DE69226402D1 (de) 1998-09-03
US5281731A (en) 1994-01-25
JPH09118641A (ja) 1997-05-06
IE921700A1 (en) 1992-12-02
EP0516410A3 (en) 1993-06-30
ATE168996T1 (de) 1998-08-15
US5486636A (en) 1996-01-23
US5597932A (en) 1997-01-28
AU1712092A (en) 1992-12-03
EP0516410A2 (en) 1992-12-02
KR920021505A (ko) 1992-12-18
JP3320025B2 (ja) 2002-09-03
US5581006A (en) 1996-12-03
US5616759A (en) 1997-04-01
JP3494637B2 (ja) 2004-02-09
KR0160937B1 (ko) 1999-01-15
CA2191993A1 (en) 1992-11-29
US5563286A (en) 1996-10-08
CA2069374C (en) 1999-08-31
KR0160936B1 (ko) 1999-01-15
JP2648845B2 (ja) 1997-09-03
JP2002201197A (ja) 2002-07-16
AU5932594A (en) 1994-06-02
JPH11240891A (ja) 1999-09-07
DE69226402T2 (de) 1998-12-10
CA2069374A1 (en) 1992-11-29
JP2926008B2 (ja) 1999-07-28
DK0516410T3 (da) 1998-10-26
AU650751B2 (en) 1994-06-30
US5391755A (en) 1995-02-21

Similar Documents

Publication Publication Date Title
ES2118794T3 (es) Nueva sintesis de compuestos de 19-nor-vitamina d.
AU4726685A (en) Internal mold release compositions, active hydrogen- containing compositions containing the internal mold release compositions & process for preparing molded polyurethane and
IT7927250A0 (it) Composizione a base di magnesio per l'immagazzinamento di idrogeno eprocedimento per la preparazione di tale composizione.
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
EP0401357A1 (en) METHOD FOR IMPROVING REPRODUCTIVE FUNCTIONS IN MAMMALS.
GR3029334T3 (en) Novel use of 1alpha-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
IT1137353B (it) Procedimento per la fabbricazione di rivestimenti ascellari a perdere a due alette nonche' rivestimento ottenuto mediante tale procedimento
AU573734B2 (en) Silanised and anti seborrheic cosmetic compositions
WO2000010548A3 (en) 19-nor-vitamin d3 compounds with calcemic activity
DE3061398D1 (en) Substituted alkylammonium salts, their preparation and use in plant growth regulation
EP0808832A3 (en) Fluorinated vitamin D3 analogs
IT8109380A0 (it) Procedimento ed attrezzatura per la realizzazione di calzature aperte con fondo stampato in resina, e calzature cosi' realizzate
IL89392A (en) Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3
AU5616190A (en) P-substituted propane-phosphinic acid compounds
DE3683158D1 (de) Faerbende zusammensetzung.
ZW28281A1 (en) New bicyclo (2.2.1) heptane derivatives a process for the preparation thereof and plant growth regulating compositions containing same
DE69128763T2 (de) Zusammensetzung, die Polyetherverbindungen enthält, Prozess zu ihrer Herstellung sowie Licht härtbare Harzzusammensetzungen
IT8420577A1 (it) "procedimento per la fabbricazione di suole di scarpe stampo per l'esecuzione di questo procedimento"
ATE32063T1 (de) Iminosulfonamide und verfahren zu ihrer herstellung, die pharmazeutische praeparate solche verbindungen enthalten, sowie die verbindungen zur verwendung.
EP0085170A3 (de) Norbornanverbindungen und diese enthaltende Mittel zur Regulierung des Pflanzenwachstums sowie deren Vorprodukte
JPS52148612A (en) Fva and its preparation
IT8620451A0 (it) Struttura di valvola con serratura di sicurezza per il controllo dell'otturatore.
IT7822114V0 (it) Meccanismo per la regolazione dell'apertura di visiere di caschi integrali.
IT8109569A0 (it) Attrezzatura per il montaggio di fibbie,per calzature femminili esimili,in due parti articolate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 516410

Country of ref document: ES